Core Viewpoint - Liu Qiangdong is returning to his hometown to distribute red envelopes while announcing the upcoming IPO of his seventh company, JD Intelligent Infrastructure Co., Ltd. [1] Group 1: Company Overview - JD Intelligent Infrastructure Co., Ltd., referred to as "JD Infrastructure," submitted its prospectus to the Hong Kong Stock Exchange on January 26, with major underwriters including Bank of America and Goldman Sachs [3] - This is not the first attempt at an IPO; the company previously submitted a prospectus in March 2023 but had to terminate it for unspecified reasons [3] - JD Infrastructure serves as JD's "facility manager," focusing on the development and operation of modern infrastructure, including logistics parks, industrial parks, and data centers [3] Group 2: Business Operations - As of September 2025, JD Infrastructure plans to have 285 infrastructure projects globally, comprising 259 logistics parks, 20 industrial parks, and 6 data centers, with a total construction area of 27.1 million square meters, equivalent to approximately 3,800 football fields [3] - The asset management scale of the company has surpassed 120 billion yuan [3] - In terms of industry ranking, JD Infrastructure is among the top three modern infrastructure providers in the Asia-Pacific region and ranks second in China [3] Group 3: Financial Performance - The company reported revenues of 2.868 billion yuan in 2023, projected to increase to 3.417 billion yuan in 2024, with 3.002 billion yuan already achieved in the first nine months of 2025, indicating solid profitability [3] Group 4: JD's Business Ecosystem - JD has successfully listed six companies prior to JD Infrastructure, including JD Group, JD Health, JD Logistics, Debon Holdings, Dada Group, and JD Industrial, establishing a diversified business empire [5] - The various sectors covered by JD, including retail, logistics, health, industrial, and infrastructure, allow for independent financing and synergistic effects among the companies [5] - JD Infrastructure's potential IPO could provide additional capital for overseas expansion, enhancing JD's influence in the capital markets [5][7]

在互联网医疗经历了数年的"线上问诊"与"医药电商"的流量争夺战后，单纯的线上流量红利似乎已触及 天花板。对于行业巨头而言，当下的命题不再是非此即彼的线上或线下之争，而是如何打破业务边界， 发挥"1+1>2"的效果。 在此背景下，京东健康正在把触角延伸至线下体检领域，试图构建起"医+检+诊+药"的完整闭环。 1月27日，京东健康对外公开了体检业务的发展情况，"谨慎"与"克制"成为该业务布局的关键词。 从数量上看，京东健康的体检机构目前仅有5家，主要分布于北京和广东。 在战略逻辑上，体检承担着将低频的线下数据与线上高频服务无缝对接的职能。一旦用户在体检中发现 异常，即可通过京东健康的线上资源，实现从报告解读、复诊到用药的"一站式"解决。 这种连接能力不仅体现在线上，更延伸至线下的物理空间，形成了独特的"体检+专科"联动模式。 在京东健康的布局中，体检中心与自营的口腔科、医美科等专科门诊同处一地，甚至就在"楼上楼下"。 体检作为流量入口发现问题，专科门诊随即承接解决，这种"综合业态"的组合拳，正在成为京东健康提 升单客价值的关键路径。 据信风了解，目前这一模式还在向减重、中医等更广泛的领域拓展。 然而，理想的C端闭 ...

在大健康产业成为国民经济重要增长极的背景下，体检行业作为健康管理的前哨阵地，正经历着一场深刻的格局重构。 京东健康消费医疗业务部体检业务负责人吴大领表示，当前体检行业呈现出明显的"两极"困境，公立医院凭借医疗资源丰富、公信力强、检后就医闭环等 核心优势，成为行业主导力量，但普遍存在服务环节缺失、体验不佳、效率较低等短板，难以满足消费者对高品质服务的需求。 "民营体检机构则以服务体验较好、套餐搭配灵活、价格亲民为亮点，但普遍面临医疗专业能力参差不齐、质控标准不一的核心问题。"吴大领认为，为避 免体检逐渐沦为"走过场"，亟需破局者重塑行业生态。 京东健康自入局体检行业以来，并未简单复制现有行业模式，而是以差异化核心能力重构行业服务标准，核心表现在三个方面：专业度上媲美公立医院， 服务体验上远超传统民营体检机构，价格上保持亲民普惠。 在专业保障方面，京东健康体检中心自建医生团队，其中中级及以上职称医生占比100%，线上服务团队医生均为副高及以上职称，关键科室主任医师占 比达到22%。 长期以来，公立医院体检部与传统民营体检机构形成的"两极博弈"格局，已难以满足消费者对专业、高效、个性化健康服务的需求。行业增速从20 ...

Group 1 - JD Health has established a medical team for its health checkup centers, with 100% of the doctors holding intermediate or higher titles, and 22% of key department heads being chief physicians [1] - The online service team consists of doctors with senior titles, ensuring a high level of expertise in patient care [1] Group 2 - JD Health is promoting the application of AI technology in its health checkup centers, which has reduced the average waiting time for users by nearly 30 minutes through an intelligent triage system [2] - The AI general inspection system has improved the efficiency of report generation by 135%, leading to a reduction of 3.5 days in the average time for users to receive their health checkup reports [2]

Core Insights - JD Health's health examination center aims to establish a new professional health management institution, creating a "third pole" in China's health examination sector to break the long-standing "bipolar" pattern between public hospitals and traditional private examination institutions [1][4] Group 1: Professional Assurance - The health examination center has built its own medical team, with 100% of doctors holding intermediate or higher titles, and 22% of key department heads being chief physicians [1][4] - The center utilizes AI technology to significantly enhance service efficiency and accuracy, reducing average waiting times by nearly 30 minutes and increasing report production efficiency by 135%, leading to a 3.5-day reduction in the average time to receive examination reports [5] Group 2: Service Experience - The center is equipped with international top-brand testing equipment and has developed a unique service standard comparable to airline service, enhancing user experience through thoughtful design elements such as heated coupling agents and senior-friendly restroom facilities [5] Group 3: Integrated Health Management - Leveraging JD Health's robust supply chain and diverse medical service resources, the examination center links "medical, testing, diagnosis, and pharmacy" into a one-stop service ecosystem, creating a health management loop of "precise discovery - professional resolution - dynamic tracking" [2][5] - Post-examination, users can seamlessly access top-tier expert resources from JD Internet Hospital for further consultations, and various services like JD Pharmacy and JD Nurse at Home can quickly provide integrated solutions based on users' specific health needs [5] Group 4: Future Developments - The health examination center plans to continue deepening the application of AI technology to enhance professional services and management decision-making efficiency, while also expanding its store network to increase the coverage of the "third pole" service, allowing more users to access high-quality professional health management services [6]

Group 1 - The Hang Seng Index opened up by 0.35% and the Hang Seng Tech Index increased by 0.05% [1] - Pop Mart surged over 4%, while Zijin Mining rose nearly 3% [1] - Tencent Music and JD Health also showed significant gains [1] Group 2 - Baidu Group, Xpeng Motors, and NIO experienced notable declines [1]

Core Insights - The article highlights significant developments in the AI industry, including new product launches, funding rounds, and strategic partnerships, reflecting the rapid evolution and investment in AI technologies globally. Group 1: AI Product Developments - Baidu's Wenxin App is introducing a social feature with "multi-agent group chat" capabilities, aiming to enhance user interaction without directly competing with WeChat [8] - Anker Innovation and Feishu launched the AI hardware product "Anker AI Recording Bean," which features advanced audio recording capabilities and integrates with Feishu's AI functionalities [9] - Baidu released the official version of Wenxin Model 5.0, which supports multi-modal understanding and has 2.4 trillion parameters [17] - Baichuan Intelligence launched the M3 Plus model, which significantly reduces factual hallucinations to 2.6% [19] - Alibaba Health introduced the AI product "Hydrogen Ion," aimed at clinical and research applications with a focus on low hallucination rates [27] Group 2: AI Company Funding and Valuation - OpenEvidence, a medical AI startup, completed a $250 million Series D funding round, valuing the company at $12 billion [22] - OpenAI's CFO announced that the company's annual revenue for 2025 is projected to exceed $20 billion, a significant increase from $6 billion in 2024 [38] - ElevenLabs is negotiating new funding that could raise its valuation to $11 billion [29] - The AI startup Anthropic is seeking to raise at least $25 billion, with Sequoia Capital expected to participate [28] Group 3: AI Industry Trends and Insights - Nvidia's CEO highlighted the increasing demand for skilled tradespeople, suggesting that roles like plumbers and electricians could see six-figure salaries due to the AI-driven infrastructure boom [11] - The global AI financing events decreased by 13 compared to the previous period, with a total disclosed financing amount of 9.57 billion RMB [42] - The distribution of AI funding in China is concentrated in Guangdong and Jiangsu provinces, indicating regional investment trends [47] Group 4: AI Market Competition and Strategic Moves - Google DeepMind's CEO praised ByteDance as a leading AI company in China, suggesting they are only six months behind the cutting edge [11] - Apple plans to significantly revamp Siri into an AI chatbot, aiming to enhance its competitive position in the AI market [36] - Tesla's CEO Elon Musk is pushing for a transformation into a robotics company, with the Optimus robot as a key focus, despite production challenges [8]

Core Viewpoint - E Fund's Zhang Kun reported a decline in total assets under management to 48.383 billion yuan as of December 2025, with three A-share focused funds underperforming their benchmarks, while the E Fund Asia Select fund achieved positive returns, significantly exceeding its benchmark [1][2]. Group 1: Fund Performance - As of December 2025, the largest fund, E Fund Blue Chip Select, had a net asset value of 1.8623 yuan, with a report period net asset value growth rate of -8.93%, compared to a benchmark return of -2.63% [1]. - Three main A-share focused funds reported negative quarterly returns and failed to outperform their performance benchmarks [1]. Group 2: Portfolio Adjustments - Zhang Kun reduced holdings in major stocks such as Kweichow Moutai, Wuliangye, Luzhou Laojiao, and Shanxi Fenjiu, while also significantly reducing positions in Focus Media and China Merchants Bank [1]. - The top ten holdings of E Fund Blue Chip Select remained unchanged, including Tencent, Kweichow Moutai, and Alibaba, with notable reductions in Focus Media and increases in Alibaba [2]. Group 3: Market Outlook - Zhang Kun expressed a long-term optimistic view on the macro economy and market, predicting significant improvements in living standards and social security in China over the next decade [2]. - He emphasized the importance of a strong domestic demand market in promoting technological innovation, suggesting that improved consumer environments could enhance subscription revenues and model capabilities [3]. Group 4: Confidence in Business Models - Zhang Kun maintained confidence in the business models, competitive barriers, and cash flow generation capabilities of the companies in the portfolio, asserting that the market's perception of quality companies presents good opportunities for long-term investors [3].

易方达蓝筹精选的前十大重仓股并未发生变更，依次为：腾讯控股(00700)、贵州茅台(600519.SH)、五粮液(000858.SZ)、阿里巴巴(09988)、山西 汾酒(600809.SH)、泸州老窖(000568.SZ)、百胜中国(09987)、中国海洋石油(00883)、京东健康(06618)、分众传媒(002027.SZ)。其中，张坤较大 幅度地减持了分众传媒，还减持了泸州老窖、山西汾酒、五粮液；加仓了阿里巴巴。 | 序号 | 股票代码 | 股票名称 | 相关资讯 | 占浄值 | 持股数 | 持仓市值 | | --- | --- | --- | --- | --- | --- | --- | | | | | | 比例 | (万股) | (万元) | | 1 | 00700 | 腾讯控股 | 股吧 行情 | 9.94% | 598.00 | 361,972.83 | | 2 | 09988 | 阿里巴巴-W | 股吧 行情 | 9.93% | 2.238.00 | 361.655.12 | | 3 | 600519 | 贵州茅台 | 股吧 行情 | 9.72% | 245.11 | 353.939.85 ...

证券日报网讯 1月22日，三诺生物在互动平台回答投资者提问时表示，公司与京东健康已达成部分产品 的战略合作，双方将通过发挥三诺产品的创新技术，以及京东健康提供的全域营销、物流配送、售后服 务等全链路支持，共同构建"硬件产品-特色服务"的居家慢病管理生态。未来，公司将持续深化与京东 健康的合作，聚焦用户健康管理需求，推动产品与服务创新。关于具体销售业绩数据，请关注公司后续 披露的定期报告。 （编辑 丛可心） ...